Scope & data request
We align on deal thesis, diligence priorities, and the minimum dataset to answer underwriting questions quickly.
Day 1–2
Kickoff + data request list tailored to the transaction.
Week 1
KPI validation + early red-flag scan.
Buy-side diligence • Home Health & Hospice
Clarity on risk. Confidence in the deal.
Morris & Associates supports private equity and investors with fast, investor-grade diligence— clinical, operational, compliance, and revenue-cycle risk assessment for home health and hospice acquisitions.
•
Risk register with red/yellow/green ratings and deal impact.
Investor-ready outputs
Concise report, evidence links, and deal-impact ratings.
Deal-speed cadence
Structured sprints built for LOI-to-close timelines.
•
100-day plan tied to value creation and execution reality.
2–4 weeks
Typical sprint
Evidence
Not opinions
Deal-ready
Clear outputs
Buy-side due diligence built for investors
We focus on the items that move valuation, deal structure, and post-close outcomes—especially the clinical and operational risks that spreadsheets miss.
Clinical
Clinical quality & patient mix
Chart and documentation review, eligibility/coverage risk, outcomes trends, OASIS / hospice CQM signals, and therapy utilization patterns.
Operational
Capacity, staffing & delivery model
Field capacity, visit productivity, scheduling, staffing stability, contractor usage, branch performance, and scalability constraints.
Compliance
Regulatory & survey readiness
Conditions of Participation, state survey exposure, policies and procedures, incident management, clinical governance, and risk controls.
Revenue Cycle
Billing, denials & cash conversion
Claim quality, denial drivers, AR aging, cash acceleration opportunities, payer mix risk, and documentation-billing alignment.
Data
EMR / reporting integrity
Data completeness, KPI definitions, clinical coding consistency, reconciliation checks, and “trust level” of management reporting.
Value Creation
100-day plan & operating cadence
A prioritized roadmap: governance, metrics, SOPs, staffing, revenue cycle, and compliance initiatives that actually stick.
How engagements run
Designed for deal speed. You get clear findings, supporting evidence, and a plan investors can execute.
Underwriting support
We translate findings into deal impact: risks, mitigations, and what to bake into structure, reps, warranties, or a 100-day plan.
Week 2
Deep dives (clinical, ops, compliance, revenue cycle).
Week 3–4
Investor-ready report + readout + go-forward plan.
Deliverables (standard)
Risk register, KPI baseline, deal protections, and a 100-day plan with owners, milestones, and measurable outcomes.
Optional add-ons
Interim management support, post-close integration, revenue cycle stabilization, and compliance remediation programs.
How we work
We are independent and buyer-aligned. The work is evidence-driven and prioritized by materiality to the deal.
Why Morris & Associates
Home health and hospice have unique clinical and reimbursement dynamics. We built this practice to cover what generalist diligence misses.
Clinical + investor mindset
We connect bedside reality to underwriting logic—so you can protect returns, not just “check boxes.”
Materiality-first
Findings are ranked by deal impact and probability—no 80-page noise.
Actionable mitigation
Each issue includes specific mitigations, owners, and timing.
Built for repeatable deal flow
Our templates and playbooks are designed to plug into your pipeline and support consistent decision-making.
Standardized scoring
Red/yellow/green rating with evidence and thresholds.
Value creation tie-in
Every diligence finding maps to a post-close initiative.
Operator realism
We focus on what teams can actually execute in 100 days.
Investor diligence checklist (preview)
A few of the questions we answer in every transaction. Want the full checklist? Request it below.
Clinical
Are documentation and eligibility defensible? Are outcomes stable? Any outlier utilization patterns or complaint/survey exposure?
Ops
Is there true capacity to grow? What breaks first—staffing, scheduling, referral intake, or coverage geography?
Revenue
What is driving denials and AR aging? Is cash conversion consistent with reported margins?
Compliance
Are CoPs and state rules operationalized, or just written policies? Any latent risk from audits, incidents, or training gaps?
Data
Can we trust KPI reporting? Are definitions consistent? Do EMR extracts reconcile to financials?
Post-close
What’s the best 100-day plan: stabilization first, then scalable growth? Where are the quick wins vs. structural fixes?
Talk through your deal
Share the basics (size, geography, payer mix, EMR, timeline). We’ll respond with a proposed scope and timeline.
Request a diligence call
Direct
Phone: 520-975-1153
Email: scott@morrisandassociates.net
Typical response: same business day
Engagements available nationwide (US)
What to include
Deal timeline, target service lines (HH / hospice), number of branches, payer mix, EMR, and your key underwriting questions.
Disclaimer
Morris & Associates provides operational and clinical advisory services. This website does not constitute legal, accounting, or investment advice. All diligence findings are based on information made available by the target company and other sources at the time of review.